
DeepSeek Seeks $7.4B Round at $74B Valuation, Opens Direct Equity Stakes Ahead of 2027 IPO
The AMW Read
Firms up an already-signaled $74B valuation target with new equity-restructuring, ARR, and IPO-timeline specifics; the raise clears the capital-cycle threshold but extends rather than resolves DeepSeek's known funding trajectory.
DeepSeek Seeks $7.4B Round at $74B Valuation, Opens Direct Equity Stakes Ahead of 2027 IPO
DeepSeek is reportedly pursuing a new funding round of $7.4 billion, per the Wall Street Journal, that would lift its valuation to $74 billion from more than $50 billion in June. Proceeds are earmarked for model R&D and compute infrastructure. The round also restructures DeepSeek's equity: prior investors mostly held indirect stakes via a limited partnership controlled by founder Liang Wenfeng, while the new round opens direct ownership to a wider investor base. Existing backers Monolith Management, Shixiang, and battery maker CATL are continuing, joined by several Chinese provincial government-backed funds. DeepSeek has engaged banks and advisors and is targeting a 2027 Shanghai IPO. Annual recurring revenue has reached roughly $500 million.
These terms track what DeepSeek had already signaled this month, when API price hikes of up to 12x and the V4 Pro launch were tied to a targeted $74 billion valuation and an $8 billion raise; this report firms the number to $7.4 billion and adds equity-structure and IPO-timeline detail. The math is stretched: $7.4 billion against roughly $500 million ARR is about 14.8 times the raise-to-revenue ratio, and $74 billion prices the company near 148 times current ARR, well ahead of its disclosed commercial scale. CATL's continued backing signals a traditional manufacturing incumbent doubling down on AI, and provincial-fund participation extends a familiar state-private capital pattern in Chinese tech. Export restrictions on advanced chips raise the cost of building compute domestically, lifting the capital bar for staying at the frontier.
The shift from LP-only indirect exposure to direct equity is standard IPO-prep: a cleaner cap table and a defensible valuation mark ahead of the 2027 listing target. DeepSeek still has not disclosed losses or cash-burn pace, leaving investors to underwrite future growth rather than current unit economics. For competitors, continued access to capital at this scale despite chip export controls suggests DeepSeek can keep subsidizing research spend even while raising API prices, worth watching for how long the pricing reset holds.
